Latest for Multiple Myeloma
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about Multiple Myeloma
They eat into bone, which causes pain, fractures and a dangerous rise in blood calcium. They also pour out a single useless antibody fragment, called M protein, that thickens the blood and clogs the kidneys. The disease is called multiple myeloma because it usually shows up in many bones at once.
Keep reading about Multiple Myeloma
Doctors stage it with 2 blood tests, beta-2-microglobulin and albumin, plus genetic changes in the myeloma cells. Myeloma that has not yet caused symptoms is called smoldering myeloma and is often watched rather than treated. Myeloma that comes back after treatment is called relapsed, and myeloma that keeps growing during treatment is called refractory. Most trials describe their patients using those 2 words and the number of prior treatments.
Myeloma sits at the edge of the definition used for rare diseases in the United States. The National Cancer Institute estimated 202,793 people were living with it in 2023. Death rates have been falling about 3% a year, and the 5-year relative survival is now 63.7%, because the number of treatment options has grown so quickly.
What are the symptoms of Multiple Myeloma?
These are common symptoms of Multiple Myeloma, and how strong they are varies from person to person.
- Bone pain, most often in the back or ribs
- Bones that break easily
- Frequent infections or a fever with no clear cause
- Tiredness and shortness of breath from low red blood cells
- Easy bruising or bleeding
- Weakness in the arms or legs
Who gets Multiple Myeloma?
Myeloma is a disease of older adults. The median age at diagnosis is 69, and about a third of cases are found between ages 65 and 74. Men are diagnosed more often than women (9.1 versus 6.1 per 100,000 a year), and Black Americans are diagnosed at 2 to 2.5 times the rate of white Americans. A silent precursor stage called MGUS, in which the abnormal protein shows up on a blood test but causes no harm, is a recognized risk factor. Radiation and certain chemical exposures also raise risk.
Next steps: find trials you might fitcompare treatmentsget help payingget alerts
Which medicines are FDA-approved for Multiple Myeloma?
There are currently 28 FDA-approved medications for Multiple Myeloma.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Which new Multiple Myeloma medicines are in trials?
Investigational medicines Trial Friend tracks for Multiple Myeloma, with trial results, safety findings and where each one stands.
How to get help paying for Multiple Myeloma treatment
Charity funds and drugmaker programs for Multiple Myeloma, checked at the source.
- From a charity · HealthWell FoundationMultiple Myeloma (Medicare Access) fundOpen
Pays for: Copays, premiums or other treatment costs. Medicare patients only.
- Carvykti (Ciltacabtagene autoleucel) · MyCARVYKTI Patient Support Program
- Abecma (Idecabtagene vicleucel) · Cell Therapy 360
- Tecvayli (Teclistamab-cqyv) · Tecvayli withMe (J&J withMe)
- Elrexfio (Elranatamab-bcmm) · Pfizer Oncology Together
- Talvey (Talquetamab-tgvs) · Talvey withMe (J&J withMe)
- Lynozyfic (Linvoseltamab-gcpt) · Lynozyfic Surround
- Blenrep (Belantamab mafodotin-blmf) · Together with BLENREP
- Darzalex (Daratumumab) · DARZALEX withMe (J&J withMe)
- Sarclisa (Isatuximab-irfc) · Sanofi CareASSIST
- Empliciti (Elotuzumab) · BMS Access Support
- Velcade (Bortezomib) · Takeda Oncology Here2Assist
- Kyprolis (Carfilzomib) · Amgen SupportPlus
- Ninlaro (Ixazomib) · Takeda Oncology Here2Assist
- Revlimid (Lenalidomide) · BMS Access Support
- Pomalyst (Pomalidomide) · BMS Access Support
- Thalomid (Thalidomide) · BMS Access Support
- Zenbexus (Iberdomide) · BMS Access Support
- Xpovio (Selinexor) · KaryForward
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Multiple Myeloma
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Multiple Myeloma resources
Reputable organizations and medical references for learning more about Multiple Myeloma, including disease registries, foundation resources, and clinical guidelines.
- NCI SEER - Cancer Stat Facts: Myeloma
- NCI PDQ - Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment, Patient Version
- Gilead - Gilead Sciences to Acquire Arcellx (anito-cel BLA and PDUFA date, February 23, 2026)
- Bristol Myers Squibb - FDA Accepts New Drug Application for Mezigdomide (July 13, 2026)